However, the increased expression of ALKBH5 is related to the poor prognosis of AML patients (31, 33, 50), which is due to increased leukemic stem cells’/leukemiainitiating cells’ (LSCs/LICs) self-renewal. This evidence concerns the gene ALKBH5 and acute myeloid leukemia.